Ghrelin vs Leptin: How the Two Appetite Hormones Differ

The short version, in plain language

Ghrelin and leptin are often described as opposites, and at the level of a first approximation that framing holds. Ghrelin is a small peptide produced mostly by cells in the stomach lining, and a 2025 review in Peptides described it as the orexigenic signal that rises in the fasted state and promotes food intake, while leptin was described as the adiposity signal released from fat tissue broadly in proportion to fat mass (PMID 39983918). One is a short term, meal related signal. The other is a slower, stock taking signal about how much energy the body has banked.

The more interesting differences sit underneath that summary: the two molecules are built differently, bind unrelated receptors, run on different time scales, and behave differently in people with higher body fat. This page compares the biology. For a deeper single hormone treatment, see the ghrelin overview, the leptin physiology page, and how ghrelin works.

This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about appetite, weight or metabolic health.

Source tissue: stomach versus adipose

Ghrelin is produced principally by endocrine cells of the gastric mucosa, with smaller contributions from the intestine and other tissues. Because its main source is the gut, ghrelin sits inside the gut to brain communication system that researchers describe when discussing how food intake is regulated after gastrointestinal surgery (PMID 23770707).

Leptin is produced primarily by white adipose tissue. Its output therefore reflects a tissue that changes slowly: fat mass accumulates or shrinks over weeks and months, not over the course of a single meal. A 2025 review of appetite regulation in obesity discussed leptin in exactly this role, as a peripheral signal reporting energy stores to central circuits, alongside ghrelin as the counterbalancing hunger signal (PMID 39983918).

Structure: a short acylated peptide versus a cytokine like protein

Ghrelin is a 28 amino acid peptide. Its defining chemical feature is an acyl group attached to the serine at position three, added by the enzyme ghrelin O acyltransferase. That fatty acid modification is what allows ghrelin to activate its classical receptor, which is why laboratories distinguish acylated ghrelin from total ghrelin when they report results. Reviews of appetite regulation in obesity treat acylated ghrelin as the biologically active form relevant to feeding behaviour (PMID 39983918).

Leptin is a much larger molecule: a roughly 16 kilodalton protein product of the LEP gene, folded into a four helix bundle that structurally resembles the long chain helical cytokines. It carries no lipid modification and circulates both free and bound to soluble receptor. The size and class difference matters practically, because the two analytes require different immunoassay chemistry and different sample handling.

Receptors and downstream signalling

Ghrelin acts at the growth hormone secretagogue receptor type 1a, a G protein coupled receptor expressed densely in the hypothalamic arcuate nucleus, the pituitary and parts of the brainstem and midbrain. Activation stimulates intracellular calcium signalling and, in the pituitary, growth hormone release, which is how the receptor was originally named before ghrelin itself was identified.

Leptin acts at the leptin receptor, a single transmembrane class I cytokine receptor whose long isoform signals through JAK2 and STAT3. The two systems are therefore unrelated at the receptor level, and their apparent opposition is a property of the circuits they feed into rather than of competition at a shared binding site. Work on homeostatic and motivational control of eating described both signals as acting on overlapping hypothalamic and mesolimbic pathways that integrate energy state with the reward value of food (PMID 27911750).

Side by side comparison

Signal timing: the meal clock versus the energy ledger

The clearest functional split between the two hormones is temporal. Ghrelin concentrations in humans vary across the day around meals, which is why study protocols that sample ghrelin generally use repeated timed blood draws rather than a single morning sample. Leptin varies far less from hour to hour in a stable state, so a single fasting sample is more often treated as informative about chronic energy status.

This timing difference also shapes how each hormone behaves in intervention research. Reviews of appetite control and energy balance in the context of exercise discussed acute and longer term influences on appetite related hormones and on subjective appetite, noting that short term perturbations do not translate directly into long term changes in energy balance (PMID 25614205). A single acute measurement of a fast moving signal such as ghrelin is not the same evidence as a sustained change in an adiposity signal such as leptin.

Fasting, body fat and the obesity picture

In the fasted state ghrelin rises, consistent with its description as the orexigenic arm of the system in a 2025 appetite review (PMID 39983918). Leptin falls with sustained negative energy balance because the signal tracks stored fat rather than the contents of the stomach.

In obesity the relationship becomes less symmetrical. Circulating leptin is typically high, yet the expected suppression of food intake is attenuated, a pattern discussed under the heading of reduced leptin responsiveness in a 2025 review of obesity as a multifactorial chronic disease with molecular and systemic components (PMID 41150735). The 2025 Peptides review examined leptin and ghrelin together in obesity for the same reason: the two signals cannot be interpreted independently of body composition (PMID 39983918).

Gastrointestinal surgery provides another window on the difference. Reviews of physiological appetite regulation in the bariatric surgery setting described substantial changes in gut derived appetite hormones after anatomical alteration of the stomach and intestine (PMID 38546831), and earlier work on the gut brain axis after surgery framed food intake regulation as the output of multiple gut signals rather than a single hormone (PMID 23770707).

Sleep and circadian context in human studies

Sleep research is one of the most common settings in which both hormones are measured in the same participants. A review of the metabolic consequences of sleep and sleep loss reported that curtailed sleep was associated with lower leptin, higher ghrelin and increased hunger and appetite (PMID 18929315). A later systematic review of clinical trials examined sleep duration against dietary intake, desire to eat, measures of food intake and metabolic hormones, and the authors reported that results across trials were not uniform (PMID 34620371).

A 2022 review of sleep deprivation and central appetite regulation discussed the central nervous system pathways through which disrupted sleep may influence appetite signalling (PMID 36558355), while a 2023 review in Nature Reviews Endocrinology addressed insufficient sleep and circadian misalignment as contributors to obesity risk (PMID 36280789). Together these reviews illustrate why timing of sampling is a methodological issue rather than a detail: both hormones are embedded in daily rhythms.

Where the two signals meet in the brain

Both hormones reach hypothalamic circuits that contain neurons expressing agouti related peptide and neuropeptide Y, and neurons expressing proopiomelanocortin. Beyond that homeostatic core, both have been studied in relation to motivational and reward processing, and a 2016 review described the interaction between homeostatic and motivational systems in the control of food intake as central to understanding eating behaviour (PMID 27911750). Metabolic signalling has also been examined in the context of psychiatric illness, where a 2016 review in Trends in Molecular Medicine discussed overlap between metabolic regulation and mental illness (PMID 26776095).

How human studies measure ghrelin and leptin

• Fasting versus postprandial sampling. Ghrelin studies commonly use serial draws around a standardised meal because the signal changes quickly across a meal cycle.
• Acylated versus total ghrelin. Because acylation is required for classical receptor activation, assays that report total ghrelin and assays that report the acylated form are not interchangeable (PMID 39983918).
• Body composition adjustment. Leptin tracks fat mass, so comparisons between groups usually require adjustment for adiposity, a point implicit in reviews of leptin responsiveness in obesity (PMID 41150735).
• Subjective appetite scales. Many trials pair hormone concentrations with visual analogue ratings of hunger and fullness, as described in reviews of appetite control and exercise (PMID 25614205) and in trials of sleep duration (PMID 34620371).

Interpretation Limits and Mixed Findings: What Studies Report

Several limitations recur in this literature. Hormone concentrations are intermediate markers, not outcomes, and a change in a circulating value does not establish a change in eating behaviour or body weight. The systematic review of sleep duration trials reported inconsistency across studies in the hormonal and intake outcomes examined (PMID 34620371), and the exercise appetite review emphasised that acute hormonal responses sit within a wider system of compensatory behaviour (PMID 25614205). Reviews of obesity biology also frame appetite regulation as multifactorial, involving genetics, environment, adipose tissue signalling and central processing rather than any single hormone (PMID 41150735). Nothing on this page describes a way to alter either hormone, and questions about individual appetite, weight or metabolic health belong with a licensed clinician.

References

• The role of leptin and ghrelin in the regulation of appetite in obesity (Peptides, 2025)
• Obesity as a Multifactorial Chronic Disease: Molecular Mechanisms, Systemic Impact, and Emerging Digital Interventions (Current Issues in Molecular Biology, 2025)
• Homeostasis Meets Motivation in the Battle to Control Food Intake (The Journal of Neuroscience, 2016)
• Appetite control and energy balance: impact of exercise (Obesity Reviews, 2015)
• Metabolic consequences of sleep and sleep loss (Sleep Medicine, 2008)
• Effect of sleep duration on dietary intake, desire to eat, measures of food intake and metabolic hormones: A systematic review of clinical trials (Clinical Nutrition ESPEN, 2021)
• Sleep Deprivation and Central Appetite Regulation (Nutrients, 2022)
• The role of insufficient sleep and circadian misalignment in obesity (Nature Reviews Endocrinology, 2023)
• Physiological Appetite Regulation and Bariatric Surgery (Journal of Clinical Medicine, 2024)
• Regulation of food intake after surgery and the gut brain axis (Current Opinion in Clinical Nutrition and Metabolic Care, 2013)
• Metabolism and Mental Illness (Trends in Molecular Medicine, 2016)